Clinical trial
Study of NGX-4010 for the Treatment of Postherpetic Neuralgia
NCT00300222 · NeurogesX, Industry · Completed
Key facts
| NCT number | NCT00300222 |
|---|---|
| Title | Study of NGX-4010 for the Treatment of Postherpetic Neuralgia |
| Official title | A Multicenter Randomized, Double-Blind, Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia |
| Lead sponsor | NeurogesX, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Peripheral Nervous System Diseases, Pain, Neuralgia, Herpes Zoster, Shingles |
| Intervention type | Drug |
| Interventions | NGX-4010 |
| Enrollment | 400 |
| Start date | Mar 1, 2006 |
| Completion | Aug 1, 2007 |
| First posted | Mar 8, 2006 |
| Last update posted | Mar 6, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: